Ann: Immutep Capital Raising Presentation, page-198

Analyst views abound,
MY VIEW,
Immutep have provided EFTI with a base to prove itself, data to date
has lots interested, however interest means nothing...
We need data to give the FDA,EMA,TGA etc cause to consider approval
for EFTI in various settings, Head and Neck the most likely from the FDA,IMO,
Aipac from EMA, TGA and others will follow suit....
In short, we need good data from EFTI trials or analysts thoughts and
prognostications mean little...
Everything is in place, the market is impatient and should be treated as
such, not worried about,,,,,
The figures from EFTI will tell the tale ..they are not that far away...